ACTRN12612000098831招募中未知
DNA Damage In Cells of Human ApoE4 Carriers and Prevention In vitro By Nutritional Supplementation with Lipophilic Antioxidants and Fatty Acids
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 35 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Inclusion Criteria
- •Aged 35-65 years; Healthy; Non-smokers; Male & Female
排除标准
- •Exclusion Criteria:
- •Mini-mental State Examination (MMSE) score of less than 20. (short mental examination); Currently diagnosed with AD or Mild cognitive impairment; On Medication for life threatening diseases (i.e. chemotherapy); Taking mineral and vitamin supplements above the RDA level on a daily basis; Taking fish oil and antioxidant supplements investigated in the study; Unable to understand the study protocol
研究者
相似试验
招募中
不适用
DNA damage response in tumours of patients with endometrial cancerEndometrial cancerNL-OMON23000ErasmusMC50
尚未招募
不适用
A clinical trial to study the prediction of result of chemotherapy in Acute myeloid leukemia by evaluating in vitro DNA damage.CTRI/2010/091/000015Dr. KH Reeta,Assistant professorDepartment of PharmacologyAIIMS, New Delhi-11002930
已完成
不适用
ltraviolet related deoxyribonucleic acid damage in skin of patients with atopic dermatitis and atopic status in relation to the use of Myfortic®Atopic dermatitisSkin and Connective Tissue DiseasesSkin conditionISRCTN23778671niversity Medical Center Utrecht (UMCU) (The Netherlands)10
进行中（未招募）
不适用
Vitamin C as an anti-cancer drugEUCTR2008-008692-33-DKDepartment of Urology, Herlev Hospital
已完成
3 期
ltraviolet related DNA-damage in skin of patients with atopic dermatitis and atopic status in relation to the use of Myfortic®atopic eczema1004090010014982atopic dermatitisNL-OMON30341niversitair Medisch Centrum Utrecht10